MIMEDX to Participate in Upcoming Investor Conferences
MIMEDX (NASDAQ: MDXG) has announced its senior management's participation in three upcoming investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MIMEDX (NASDAQ: MDXG) has announced its senior management's participation in three upcoming investor conferences. The company will attend the Craig-Hallum 22nd Annual Institutional Investor Conference in Minneapolis on May 28, 2025, the Goldman Sachs 46th Annual Global Healthcare Conference in Miami on June 11, 2025, and the virtual Northland Capital Growth Conference on June 25, 2025. All events will feature one-on-one sessions with management. Interested investors can arrange meetings through their respective conference representatives.
Details
News Market Reaction – MDXG
The recorded move for MDXG in the trading session of this news was +2.11%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MARIETTA, Ga., May 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:
Craig-Hallum 22nd Annual Institutional Investor Conference | Minneapolis, MN
1:1 sessions: Wednesday, May 28, 2025
Goldman Sachs 46th Annual Global Healthcare Conference | Miami, FL
1:1 sessions: Wednesday, June 11, 2025
Northland Capital Growth Conference | Virtual
1:1 sessions: Wednesday, June 25, 2025
Investors interested in meeting with senior management at these events may contact their respective Craig-Hallum, Goldman Sachs or Northland representative.
About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.
Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.